Product Information
LORAZEPAM 2 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.0697 per EA under NDC 62559019701. Its NADAC has been published 68 times since May 7, 2025.
FDA first approved this application on Dec 13, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559019701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077396FDA Approved
12/13/2006
TE Code
AB
On Market Since
12/1/2024
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 2 MG TABLET has been published 68 times since May 7, 2025, and over the history we have for it it has declined 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0697 per EA |
|---|---|
| All-time high | $0.0764 (Oct 15, 2025) |
| All-time low | $0.0695 (Feb 18, 2026) |
| 52-week high | $0.0764 |
| 52-week low | $0.0695 |
| Median price | $0.0727 |
| Average price | $0.0727 |
| Largest weekly change | -4.2% (Dec 17, 2025) |
| Weeks tracked | 68 |
| Tracking since | May 7, 2025 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LORAZEPAM 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 2 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.0697 per EA (NDC 62559019701), effective Aug 19, 2026.
How has the price of LORAZEPAM 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 2 MG TABLET has declined 4.8%. It has been tracked across 68 weekly CMS publications since May 7, 2025.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 2 MG TABLET?
Since May 7, 2025, the NADAC for LORAZEPAM 2 MG TABLET has ranged from a low of $0.0695 (Feb 18, 2026) to a high of $0.0764 (Oct 15, 2025), with a median of $0.0727 per EA.
Are there cheaper alternatives to LORAZEPAM 2 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LORAZEPAM 2 MG TABLET, is $0.0424 per EA — about 39% below LORAZEPAM 2 MG TABLET.
Who manufactures LORAZEPAM 2 MG TABLET?
LORAZEPAM 2 MG TABLET (NDC 62559019701) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.